Chlorogenic Acid Inhibits Progressive Pulmonary Fibrosis in a Diabetic Rat Model

Overview

Journal Iran J Med Sci

Publisher Shiraz University of Medical Sciences

Specialty General Medicine

Date 2024 Feb 15

PMID 38356488

Authors

Sagita Mega Sekar Kencana

Nur Arfian

Ratih Yuniartha

Ramadhea Laila Afifa An-Nur Willya Saputri

Fauziyatul Munawaroh

Dwi Cahyani Ratna Sari

Affiliations

Soon will be listed here.

Abstract

Background: Chlorogenic acid (CGA) is known to have antifibrotic and hypoglycemic effects and may play a role in preventing diabetes-induced pulmonary fibrosis. This study aimed to determine the effect and optimum dose of CGA on diabetes-induced pulmonary fibrosis.

Methods: Thirty Wistar rats (two-month-old, 150-200 grams) were randomly divided into six groups, namely control, six weeks diabetes mellitus (DM1), eight weeks DM (DM2), and three DM2 groups (CGA1, CGA2, and CGA3) who received CGA doses of 12.5, 25, and 50 mg/Kg BW, respectively. After six weeks, CGA was administered intraperitoneally for 14 consecutive days. Lung tissues were taken for TGF-β1, CTGF, SMAD7, Collagen-1, and α-SMA mRNA expression analysis and paraffin embedding. Data were analyzed using one-way ANOVA and the Kruskal-Wallis test. P<0.05 was considered statistically significant.

Results: TGF-β1 expression in the CGA1 group (1.01±0.10) was lower than the DM1 (1.33±0.25, P=0.05) and DM2 (1.33±0.20, P=0.021) groups. α-SMA expression in the CGA1 group (median 0.60, IQR: 0.34-0.64) was lower than the DM1 (median 0.44, IQR: 0.42-0.80) and DM2 (median 0.76, IQR: 0.66-1.10) groups. Collagen-1 expression in the CGA1 group (0.75±0.13) was lower than the DM1 (P=0.24) and DM2 (P=0.26) groups, but not statistically significant. CTGF expression in CGA groups was lower than the DM groups (P=0.088), but not statistically significant. There was an increase in SMAD7 expression in CGA groups (P=0.286). Histological analysis showed fibrosis improvement in the CGA1 group compared to the DM groups.

Conclusion: CGA (12.5 mg/Kg BW) inhibited the expression of profibrotic factors and increased antifibrotic factors in DM-induced rats.

References

Rout-Pitt N, Farrow N, Parsons D, Donnelley M . Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology. Respir Res. 2018; 19(1):136. PMC: 6052671. DOI: 10.1186/s12931-018-0834-8. View

Wang D, Ma Y, Tong X, Zhang Y, Fan H . Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis. Front Public Health. 2020; 8:196. PMC: 7285959. DOI: 10.3389/fpubh.2020.00196. View

Upadhyay S, Dixit M . Role of Polyphenols and Other Phytochemicals on Molecular Signaling. Oxid Med Cell Longev. 2015; 2015:504253. PMC: 4477245. DOI: 10.1155/2015/504253. View

Bai L, Zhang L, Pan T, Wang W, Wang D, Turner C . Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review. Respir Res. 2021; 22(1):175. PMC: 8188656. DOI: 10.1186/s12931-021-01760-6. View

Bagdas D, Etoz B, Inan Ozturkoglu S, Cinkilic N, Ozyigit M, Gul Z . Effects of systemic chlorogenic acid on random-pattern dorsal skin flap survival in diabetic rats. Biol Pharm Bull. 2014; 37(3):361-70. DOI: 10.1248/bpb.b13-00635. View

Leon-Gonzalez A, Auger C, Schini-Kerth V . Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem Pharmacol. 2015; 98(3):371-80. DOI: 10.1016/j.bcp.2015.07.017. View

Schuyler M, Niewoehner D, INKLEY S, Kohn R . Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis. 1976; 113(1):37-41. DOI: 10.1164/arrd.1976.113.1.37. View

Wuyts W, Agostini C, Antoniou K, Bouros D, Chambers R, Cottin V . The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J. 2012; 41(5):1207-18. DOI: 10.1183/09031936.00073012. View

Shi H, Dong L, Jiang J, Zhao J, Zhao G, Dang X . Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology. 2012; 303:107-14. DOI: 10.1016/j.tox.2012.10.025. View

10.

Sotler R, Poljsak B, Dahmane R, Jukic T, Jukic D, Rotim C . PROOXIDANT ACTIVITIES OF ANTIOXIDANTS AND THEIR IMPACT ON HEALTH. Acta Clin Croat. 2020; 58(4):726-736. PMC: 7314298. DOI: 10.20471/acc.2019.58.04.20. View

11.

Saito A, Horie M, Nagase T . TGF-β Signaling in Lung Health and Disease. Int J Mol Sci. 2018; 19(8). PMC: 6121238. DOI: 10.3390/ijms19082460. View

12.

Suh K, Chon S, Oh S, Kim S, Kim J, Kim Y . Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line. Cell Biol Toxicol. 2009; 26(3):189-99. DOI: 10.1007/s10565-009-9137-7. View

13.

Alam S, Sarker M, Sultana T, Chowdhury M, Rashid M, Chaity N . Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development. Front Endocrinol (Lausanne). 2022; 13:800714. PMC: 8907382. DOI: 10.3389/fendo.2022.800714. View

14.

Lipson K, Wong C, Teng Y, Spong S . CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012; 5(Suppl 1):S24. PMC: 3368796. DOI: 10.1186/1755-1536-5-S1-S24. View

15.

Chu K, Chan S, Pang C, Wang C . Pro-oxidative and antioxidative controls and signaling modification of polyphenolic phytochemicals: contribution to health promotion and disease prevention?. J Agric Food Chem. 2014; 62(18):4026-38. DOI: 10.1021/jf500080z. View

16.

Mummidi S, Das N, Carpenter A, Kandikattu H, Krenz M, Siebenlist U . Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo. J Mol Cell Cardiol. 2016; 98:95-102. DOI: 10.1016/j.yjmcc.2016.07.006. View

17.

Nicholas S . Novel Anti-inflammatory and Anti-fibrotic Agents for Diabetic Kidney Disease-From Bench to Bedside. Adv Chronic Kidney Dis. 2021; 28(4):378-390. DOI: 10.1053/j.ackd.2021.09.010. View

18.

Kilkenny C, Browne W, Cuthill I, Emerson M, Altman D . Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010; 8(6):e1000412. PMC: 2893951. DOI: 10.1371/journal.pbio.1000412. View

19.

Yang F, Luo L, Zhu Z, Zhou X, Wang Y, Xue J . Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway and . Front Pharmacol. 2018; 8:929. PMC: 5742161. DOI: 10.3389/fphar.2017.00929. View

20.

Qin L, Zang M, Xu Y, Zhao R, Wang Y, Mi Y . Chlorogenic Acid Alleviates Hyperglycemia-Induced Cardiac Fibrosis through Activation of the NO/cGMP/PKG Pathway in Cardiac Fibroblasts. Mol Nutr Food Res. 2020; 65(2):e2000810. DOI: 10.1002/mnfr.202000810. View